These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38993032)

  • 1. Development and qualification of 3 L scale-down model for large scale vaccine process on Vero cell culture using microcarriers.
    Huang R; Wang K; Flamm MH; Vazquez J; Gercke C; Ton C; Whitmer T; Mathis PK; Ploeger KJM; Rameez S
    Biotechnol Bioeng; 2024 Nov; 121(11):3402-3414. PubMed ID: 38993032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A scale-down model of 4000-L cell culture process for inactivated foot-and-mouth disease vaccine production.
    Li XR; Yang YK; Wang RB; An FL; Zhang YD; Nie JQ; Ahamada H; Liu XX; Liu CL; Deng Y; Bai ZH; Li Y; Liu XR
    Vaccine; 2019 Oct; 37(43):6380-6389. PubMed ID: 31519448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioreactor production of rVSV-based vectors in Vero cell suspension cultures.
    Kiesslich S; Kim GN; Shen CF; Kang CY; Kamen AA
    Biotechnol Bioeng; 2021 Jul; 118(7):2649-2659. PubMed ID: 33837958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media.
    Rourou S; Ben Zakkour M; Kallel H
    Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.
    Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK
    BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of Newcastle disease virus by Vero cells grown on cytodex 1 microcarriers in a 2-litre stirred tank bioreactor.
    Arifin MA; Mel M; Abdul Karim MI; Ideris A
    J Biomed Biotechnol; 2010; 2010():586363. PubMed ID: 20625497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of suspension adapted Vero cell culture process technology for production of viral vaccines.
    Shen CF; Guilbault C; Li X; Elahi SM; Ansorge S; Kamen A; Gilbert R
    Vaccine; 2019 Nov; 37(47):6996-7002. PubMed ID: 31288997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing viral vaccine production using engineered knockout vero cell lines - A second look.
    Hoeksema F; Karpilow J; Luitjens A; Lagerwerf F; Havenga M; Groothuizen M; Gillissen G; Lemckert AAC; Jiang B; Tripp RA; Yallop C
    Vaccine; 2018 Apr; 36(16):2093-2103. PubMed ID: 29555218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor.
    Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H
    Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Qualification of a Scale-Down Mammalian Cell Culture Model and Application in Design Space Development by Definitive Screening Design.
    Nie L; Gao D; Jiang H; Gou J; Li L; Hu F; Guo T; Wang H; Qu H
    AAPS PharmSciTech; 2019 Jul; 20(6):246. PubMed ID: 31286304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in-silico analysis of hydrodynamics and gas mass transfer characteristics in scale-down models for mammalian cell cultures.
    Anand A; McCahill M; Thomas J; Sood A; Kinross J; Dasgupta A; Rajendran A
    J Biotechnol; 2024 Jun; 388():96-106. PubMed ID: 38642816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods.
    Thomassen YE; Rubingh O; Wijffels RH; van der Pol LA; Bakker WA
    Vaccine; 2014 May; 32(24):2782-8. PubMed ID: 24583004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of a live-attenuated genotype I Japanese encephalitis virus to vero cells is associated with mutations in structural protein genes.
    Anwar MN; Guo S; Xin W; Hameed M; Wahaab A; Ma X; Khan AU; Rahman SU; Shao D; Li Z; Liu K; Li B; Qiu Y; Ma Z; Wei J
    Virus Res; 2021 Jan; 292():198256. PubMed ID: 33285172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Ambr15 system for simulation of entire SARS-CoV-2 vaccine production process involving macrocarriers.
    Jayson A; Goldvaser M; Dor E; Monash A; Levin L; Cherry L; Lupu E; Natan N; Girshengorn M; Epstein E; Rosen O
    Biotechnol Prog; 2022 Sep; 38(5):e3277. PubMed ID: 35633106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of large scale production of homologous live attenuated PPR vaccine in India.
    Hegde R; Gomes AR; Byregowda SM; Hugar P; Giridhar P; Renukaprasad C
    Trop Anim Health Prod; 2008 Jan; 40(1):11-6. PubMed ID: 18551773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-Scale Cell Production Based on GMP-Grade Dissolvable Porous Microcarriers.
    Chen Y; Xu H; Zhang Y; Guo L; Lan M; Yang Y; Liu W; Yan X; Du Y
    J Vis Exp; 2023 Jul; (197):. PubMed ID: 37486127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Process intensification for Peste des Petites Ruminants Virus vaccine production.
    Sousa M; Fenge C; Rupprecht J; Tappe A; Greller G; Alves P; Carrondo M; Roldão A
    Vaccine; 2019 Nov; 37(47):7041-7051. PubMed ID: 31402239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production Process Development of Pseudorabies Virus Vaccine by Using a Novel Scale-Down Model of a Fixed-Bed Bioreactor.
    Nie J; Sun Y; Peng F; Li X; Yang Y; Liu X; Li Y; Liu C; Bai Z
    J Pharm Sci; 2020 Feb; 109(2):959-965. PubMed ID: 31604085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a high-yield live-virus vaccine production platform using a novel fixed-bed bioreactor.
    Berrie DM; Waters RC; Montoya C; Chatel A; Vela EM
    Vaccine; 2020 Apr; 38(20):3639-3645. PubMed ID: 32247568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vero cell upstream bioprocess development for the production of viral vectors and vaccines.
    Kiesslich S; Kamen AA
    Biotechnol Adv; 2020 Nov; 44():107608. PubMed ID: 32768520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.